FY24 peer reviewed dmrdp - psychedelic treatment research clinical trial award
Ended Awarded Last action
- Contract number
- HT942524F0246
- Awardee
-
General Dynamics Information Technology, Inc. UEI SMNWM6HN79X5 Part of General Dynamics Corp
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $69,463
Award facts
- Opportunity
-
- Biomedical Research Application Evaluation and Support - Presolicitation Notice Pre-Solicitation · W81XWH21R0001 · Posted Apr 8, 2021
- Contract value 72% obligated
- $95,890.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 813920 Professional Organizations
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Falls Church, VA 22042, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$13,097 | |
| Funding Only Action | -$13,331 | |
| Original award | $95,891 |
About this award
General Dynamics Information Technology, Inc. (GDIT) was awarded a $95,890.94 delivery order on July 29, 2024, under the FY24 Peer Reviewed Defense Medical Research and Development Program (DMRDP) for Psychedelic Treatment Research Clinical Trial. The contract is funded by the Defense Health Agency and is structured as a cost-plus-fixed-fee arrangement with an ultimate completion date of July 28, 2025. Work will be performed in Falls Church, Virginia. This award was made through unrestricted competition with no set-aside designation and represents GDIT's continued involvement in medical research initiatives supporting the Department of Defense. As a subsidiary of General Dynamics Corporation, GDIT brings extensive capabilities in research support and technical services across multiple federal agencies.
The Defense Medical Research and Development Program invests in peer-reviewed research to address critical medical challenges affecting military readiness and personnel health. GDIT's award demonstrates the Defense Health Agency's commitment to exploring innovative treatment modalities, including psychedelic-assisted therapies, as potential interventions for service members. GDIT's established track record in medical research, exemplified by previous grants such as the $1.25 million initiative on traumatic brain injury treatment interventions, positions the company to execute clinical trial support activities effectively. The modest ceiling value reflects the specific scope of this delivery order within what is likely a broader research portfolio administered through the DMRDP framework.
Quick answers
Who was awarded contract HT942524F0246?
HT942524F0246 was awarded to General Dynamics Information Technology, Inc. by Defense Health Agency (Department of Defense) on July 29, 2024.
How much is contract HT942524F0246 worth?
The government has obligated $69,463 on HT942524F0246. Its current value, with exercised options, is $95,891.
Is contract HT942524F0246 an order under another contract?
Yes. HT942524F0246 is a delivery order under W81XWH22D0004, an indefinite delivery contract.
Was contract HT942524F0246 competed?
The extent of competition for HT942524F0246 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award